Skip to main content
Sailong Pharmaceutical Group Co., Ltd. logo

Sailong Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002898 ISIN · CNE1000032S5 LEI · 8368004F5Y6BSB6US681 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,117 across all filing types
Latest filing 2021-04-18 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002898

About Sailong Pharmaceutical Group Co., Ltd.

https://www.sailong.cn

Sailong Pharmaceutical Group Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and marketing of high-end generic drugs and innovative formulations. The company maintains an integrated industrial chain encompassing active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily targets therapeutic areas such as cardiovascular and cerebrovascular diseases, the digestive system, and anti-infective treatments. Key products include Monosialotetrahexosylganglioside Sodium Injection and Pantoprazole Sodium for Injection. The group emphasizes technological innovation and quality control to provide clinical solutions for complex medical conditions.

Recent filings

Filing Released Lang Actions
关于完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of a business registration change, specifically the change in registered capital and the issuance of a new business license. It references board and shareholder meetings approving amendments to the company's articles of association. The document is short (693 characters) and serves as a formal notice of the completion of a corporate registration update rather than a detailed financial report or regulatory filing. It does not contain financial statements, audit information, or detailed management discussion. This fits best with a Regulatory Filing (RNS) as it is a general regulatory announcement about corporate changes that do not fall under more specific categories like capital changes (SHA) or management changes (MANG).
2021-04-18 Chinese
关于公司2021年第一季度业绩预告
Earnings Release Classification · 95% confidence The document is a quarterly earnings forecast for the first quarter of 2021, including estimated net profit and earnings per share, with a note that the forecast is unaudited and preliminary. It explicitly states it is a performance forecast, not the actual financial report. The document length is short (885 characters), and it does not contain actual financial statements or detailed analysis, only an earnings preview. Therefore, it fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly financial results or key highlights. Q1 2021
2021-04-14 Chinese
关于归还暂时补充流动资金的闲置募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (641 characters) from Zhuhai Sailong Pharmaceutical Co., Ltd. regarding the repayment of temporarily supplemented idle raised funds used for working capital. It references a previous board meeting decision and confirms the full repayment of the funds. There are no financial statements or detailed financial data presented, only a disclosure about the status of the use and repayment of raised funds. This fits the description of a Capital/Financing Update (CAP) as it relates to the company's financing activities and capital usage updates. The document is not a full report, nor an announcement of a report publication, but a specific update on capital usage.
2021-04-13 Chinese
关于聘任公司高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement from Zhuhai Sailong Pharmaceutical Co., Ltd. regarding the appointment of senior management personnel. It details the approval of appointments by the board, provides biographies of the appointed individuals, and confirms their qualifications and compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses solely on management changes. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 3183 characters, which is consistent with a detailed announcement rather than a full report.
2021-04-07 Chinese
关于监事会完成换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the completion of the supervisory board (监事会) re-election at Zhuhai Sailong Pharmaceutical Co., Ltd. It details the election of new supervisory board members and the appointment of the chairman of the supervisory board. It includes references to previous announcements and confirms compliance with legal and regulatory requirements. There is no financial data, no mention of annual or interim reports, no voting results from a general meeting, and no mention of dividends or capital changes. The document is a formal announcement about board/management changes specifically related to the supervisory board, which falls under Board/Management Information (MANG). The document length is short and it is not a report or a notice of report publication, so it is not RPA or RNS. Therefore, the correct classification is MANG with high confidence.
2021-04-07 Chinese
第三届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution from the first meeting of the third Supervisory Board of Zhuhai Sailong Pharmaceutical Co., Ltd. It details the election of the chairman of the Supervisory Board and confirms the meeting's compliance with legal and regulatory requirements. There is no financial data, no mention of annual or interim reports, no audit information, no earnings data, and no investor presentation. The document is a corporate governance announcement related to board or supervisory committee changes. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS. Confidence is high due to clear content and context.
2021-04-07 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.